ALBANY – New York’s fledgling medical marijuana program might soon be able to offer patients marijuana-infused lotions, patches and chewables under new regulations proposed by the state’s Department of Health.
Chewable and effervescent medical marijuana tablets, along with lozenges and certain “non-smokable forms of ground plant material,” could soon be eligible to residents with severe illnesses, such as cancer, HIV, AIDS, ALS or Parkinson’s disease. Currently, eligible patients are able to ingest medical marijuana through capsules and liquids or oils for vaporizing. The proposed regulations are slated to be published in the State Register on Aug. 23, where they’ll be subject to a 30-day comment period before being adopted by the Department of Health.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
